TESTOSTERONE ENANTHATE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0143-9750 -
Package NDC
0143-9750-01 -
Application number
ANDA091120 -
SPL ID
8d67aa07-833f-4be7-8a7e-e49e19f49949 -
SPL set ID
e89d6458-428c-4256-97a3-f1fa851293c1 -
UNII
7Z6522T8N9 -
RxCUI
835809
What the source publishes
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Active ingredients
- TESTOSTERONE ENANTHATE
- Form
- INJECTION, SOLUTION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TESTOSTERONE ENANTHATE",
"splId": "8d67aa07-833f-4be7-8a7e-e49e19f49949",
"labels": [
{
"setId": "e89d6458-428c-4256-97a3-f1fa851293c1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e89d6458-428c-4256-97a3-f1fa851293c1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e89d6458-428c-4256-97a3-f1fa851293c1"
}
],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "Hikma Pharmaceuticals USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "5 mL in 1 VIAL, MULTI-DOSE (0143-9750-01)",
"package_ndc": "0143-9750-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20120918"
}
],
"productId": "0143-9750_8d67aa07-833f-4be7-8a7e-e49e19f49949",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0143-9750",
"deaSchedule": "CIII",
"genericName": "TESTOSTERONE ENANTHATE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TESTOSTERONE ENANTHATE",
"strength": "200 mg/mL"
}
],
"applicationNumber": "ANDA091120",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120918",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"7Z6522T8N9"
],
"rxcui": [
"835809"
],
"spl_set_id": [
"e89d6458-428c-4256-97a3-f1fa851293c1"
],
"manufacturer_name": [
"Hikma Pharmaceuticals USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0143-9750_8d67aa07-833f-4be7-8a7e-e49e19f49949"